10-QPeriod: Q3 FY2025

AXON ENTERPRISE, INC. Quarterly Report for Q3 Ended Sep 30, 2025

Filed November 5, 2025For Securities:AXON

Summary

Axon Enterprise, Inc. (AXON) reported its financial results for the period ending September 30, 2025. The company experienced a significant increase in net sales, up 30.6% year-over-year for the third quarter, reaching $710.6 million. This growth was driven by strong performance in both its Connected Devices segment (up 23.6%) and its Software and Services segment (up 41.1%). However, the company reported a net loss of $2.2 million for the quarter, a reversal from the $67.0 million net income in the prior year period. This shift was influenced by increased operating expenses, particularly in Research & Development and Selling, General & Administrative, and a higher effective tax rate, partly due to the enactment of the 'One Big Beautiful Bill Act' (OBBBA) impacting R&D tax credits. Despite the quarterly net loss, the year-to-date (nine months ended September 30, 2025) performance shows a net income of $121.9 million, albeit lower than the $241.9 million in the same period last year. The company's balance sheet reflects a robust increase in cash and cash equivalents to $1.4 billion from $454.8 million, supported by strong financing activities including the issuance of $1.75 billion in Senior Notes and proceeds from an at-the-market equity offering. Management believes current liquidity sources are sufficient to meet anticipated cash requirements for at least the next 12 months.

Financial Statements
Beta

Key Highlights

  • 1Net sales grew by 30.6% to $710.6 million in Q3 2025 compared to Q3 2024, driven by strong performance in both Connected Devices and Software & Services segments.
  • 2The company reported a net loss of $2.2 million for Q3 2025, a significant change from a net income of $67.0 million in Q3 2024, primarily due to increased operating expenses and a higher effective tax rate.
  • 3Total assets increased to $6.66 billion from $4.47 billion year-over-year, with a substantial rise in cash and cash equivalents ($1.42 billion) and short-term investments ($952.8 million).
  • 4Long-term debt increased significantly due to the issuance of $1.75 billion in Senior Notes in March 2025.
  • 5Operating expenses, specifically Selling, General & Administrative and Research & Development, increased substantially year-over-year, reflecting investments in headcount and stock-based compensation.
  • 6Remaining performance obligations (backlog) stood at approximately $8.1 billion as of September 30, 2025, indicating strong future revenue potential.

Frequently Asked Questions

The net loss of $2.2 million in the third quarter of 2025, compared to a net income in the prior year, was primarily driven by an increase in operating expenses, particularly in Selling, General & Administrative and Research & Development. Additionally, a higher effective tax rate, influenced by legislative changes affecting R&D tax credits, also contributed to the loss.

Axon issued $1.0 billion in Senior Notes due 2030 and $750.0 million in Senior Notes due 2033 in March 2025, totaling $1.75 billion in new long-term debt. This significantly increased the company's long-term liabilities compared to the prior year.

The company's liquidity has significantly improved. Cash and cash equivalents increased to $1.42 billion as of September 30, 2025, from $454.8 million at the end of 2024. This, along with short-term investments of $952.8 million, provides a strong cash position. Management expects these sources to be sufficient for at least the next 12 months.

Axon reported approximately $8.1 billion in remaining performance obligations as of September 30, 2025. This substantial backlog represents contracted revenue that is expected to be recognized over the next several years, with approximately 20%-25% anticipated within the next 12 months, indicating strong visibility for future revenue.